@ShahidNShah
Epic Research: Only 5% of Overdose Patients Tested for Fentanyl, #1 Killer of Americans 18-45
Unfortunately, patients experiencing an overdose are rarely screened for fentanyl or other synthetic opioids when they visit emergency departments (ED). Most EDs complete limited toxicology testing on patients that present for an overdose, but those toxicology panels often don't include synthetic opioids, like fentanyl. Researchers from Epic and the University of Maryland's Center for Substance Abuse Research (CESAR) used deidentified Cosmos data to study patterns in toxicology screenings from more than 315,000 emergency department (ED) overdose visits across the U.S. that occurred between 2017 and August 2022. Patients are tested for fentanyl during just 5% of overdose-related ED visits.
Continue reading at prnewswire.com
Make faster decisions with community advice
- Cadence and ScionHealth Partner to Offer Remote Care Management to Patients Managing Chronic Conditions
- CalOptima Health Selects ZeOmega for Comprehensive Set of Care Management Solutions
- Glytec and CPS Collaborate to Provide Evidence-Based Glycemic Management Support for Pharmacy Departments Nationwide
- GoodRx to lay off 16% of its workforce
- HealthTeam Advantage Integrates Bamboo Health’s Pings Solution to Strengthen Provider Collaboration and Improve Patient Outcomes
Next Article
-
Glytec and CPS Collaborate to Provide Evidence-Based Glycemic Management Support for Pharmacy Departments Nationwide
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced it has been selected by CPS Solutions, LLC (CPS), a …
Posted Sep 3, 2022 Healthcare Pharmacy